Hemab Therapeutics Holdings, Inc. COAG
45.06 USD -0.03 (-0.07%)
Nov 5, 2026, 1:11 PM EST
43.96 Day range 45.66
23.00 52-week range 55.42
- YTD
- +32.53%
- 1 year
- +32.53%
Financial health
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 3
Valuation
P/E -14.6×
FY 2025 5y median -14.6× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -5.3×
FY 2025 5y median -5.3× FY 2025
P/FCF -15.2×
FY 2025 5y median -15.2× FY 2025
EV/EBITDA -12.1×
FY 2025 5y median -12.1× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -6.6%
FY 2025 5y median -6.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 36.2%
FY 2025 5y median 36.2% FY 2025
ROIC -37.8%
FY 2025 5y median -37.8% FY 2025
ROA -32.8%
FY 2025 5y median -32.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 18.0×
FY 2025 5y median 18.0× FY 2025
Quick Ratio 18.0×
FY 2025 5y median 18.0× FY 2025
Debt / Equity -0.0×
FY 2025 5y median -0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2025 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31